Weave Communications, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a WEAV research report →
Range $7.4 – $7.4
Price Chart
About the company
Weave Communications, Inc. delivers a comprehensive software platform designed for customer communication and engagement across the United States and Canada. This platform empowers small and medium-sized businesses (SMBs) to elevate the effectiveness of their customer interactions while significantly reducing the labor involved in routine or repetitive duties.
- CEO
- Brett T. White
- IPO
- 2021
- Employees
- 904
- HQ
- Lehi, UT, US
Get TickerSpark's AI analysis on WEAV
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $595.33M
- P/E
- -29.20
- Fwd P/E
- 43.53
- PEG
- -0.63
- P/S
- 2.31
- P/B
- 6.94
- EV/EBITDA
- -507.70
- Div Yield
- 0.00%
- Gross Margin
- 72.34%
- Op Margin
- -8.25%
- Net Margin
- -7.97%
- ROE
- -24.96%
- ROIC
- -15.57%
Latest fiscal year · YoY change
- Revenue
- $239.02M+17.0%
- Gross Profit
- $172.31M+18.1%
- Op Income
- $-28,914,000
- Net Income
- $-28,052,000+1.0%
- EPS
- $-0.37+7.5%
- OCF Growth
- +24.0%
- FCF Growth
- +26.6%
- 52W High
- $7.70
- 52W Low
- $4.24
- 50D MA
- $7.27
- 200D MA
- $6.15
- Beta
- 1.68
- RSI (14)
- 63
- Avg Volume
- 2.98M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Weave delivered strong Q2 revenue growth and record location adds, but lowered full-year revenue guidance after a go-to-market transition temporarily disrupted bookings.· August 6, 2026
- Q2 revenue was $67.5 million, up 15.5% year over year, with payments growing at roughly twice the revenue rate.
- Gross margin was 72.6% and operating margin improved to 4.7%, up from roughly break-even a year ago.
- Weave added the most new locations ever in a quarter on both a gross and net basis, with dental posting its best quarter for adds in eight quarters.
- Management said the May-to-July sales transition caused bookings to come in slightly below expectations despite strong demand.
- Full-year revenue guidance was cut to $273 million-$275 million, while non-GAAP operating income guidance was raised to $12 million-$14 million.
Weave reported second-quarter 2026 total revenue of $67.5 million, up 15.5% year over year. Gross profit was $49 million, up 16% year over year, and gross margin was 72.6%, up 30 basis points year over year and down 60 basis points sequentially. Operating income was $3.2 million versus breakeven in Q2 2025, and operating margin was 4.7%, up 460 basis points year over year. The company ended the quarter with $78.5 million in cash and short-term investments, up $5.8 million sequentially; cash from operations was $10.2 million and free cash flow was $8.7 million. For Q3 2026, Weave guided to revenue of $68.6 million-$69.6 million and operating income of $3 million-$4 million. For full-year 2026, revenue is expected to be $273 million-$275 million and non-GAAP operating income $12 million-$14 million.
Brett White said Weave’s core thesis is improving healthcare practices’ scheduling, staffing efficiency, and revenue collection through its patient communication and payments platform. He emphasized record location additions, stronger dental performance, deeper AI adoption, and a significantly deeper athenaOne integration that should improve specialty medical economics over time. His tone was confident and upbeat, but he acknowledged the sales transition caused a temporary booking shortfall that is now being completed and tightened.
Jason Christiansen focused on the quarter’s mix of growth and leverage: revenue of $67.5 million, gross profit of $49 million, gross margin of 72.6%, and operating income of $3.2 million. He highlighted expense discipline, including G&A at $10 million, R&D at $10 million, and sales and marketing at $25.8 million or 38% of revenue, with S&M down 240 basis points sequentially. He also pointed to $78.5 million in cash and short-term investments, $10.2 million in operating cash flow, $8.7 million in free cash flow, and free cash flow positivity for the first half of 2026. On guidance, he lowered full-year revenue to $273 million-$275 million because of the go-to-market transition, while raising operating income guidance to $12 million-$14 million.
Analysts focused heavily on the revenue guide reduction and whether the go-to-market transition was the only issue versus any broader demand slowdown. Management said demand remained strong, and the shortfall came from lead distribution and the sales-team redesign, with the impact flowing into Q3 and Q4. Questions also centered on the size and structure of the sales team, the sustainability of dental momentum, and the athenahealth integration; management said the outbound team is smaller, the transition was accelerated and completed in early August, and deeper integrations should lift ASP, retention, and CAC over time.
The bull case is that underlying demand appears intact while Weave is improving efficiency and margins. Management pointed to record location adds, strong dental momentum, growing AI engagement, and a deeper athenaOne integration that could expand specialty medical opportunity and improve unit economics. They also emphasized operating leverage, with S&M as a percentage of revenue down and operating margin nearly 5%.
The main bear case is that the sales organization change clearly disrupted bookings, forcing management to cut revenue guidance for the year. The guidance implies the May-to-July transition will weigh on the back half, and the company acknowledged bookings were slightly below expectations despite strong demand. There is also execution risk in the new SDR/AE model and in turning AI usage and new integrations into durable revenue growth.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 73.5%
- Shares Outstanding
- 80.45M
- Float Shares
- 59.12M
of shares held by institutions
190 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 5.85M | ▲ 380.94K |
| Blackrock, Inc. | 5.41M | ▲ 96.75K |
| Crosslink Capital Inc | 4.26M | ▼ 7.27K |
| Glazer Capital, LLC | 3.77M | ▲ 3.77M |
| Fil Ltd | 3.21M | ▲ 3.21M |
| Vanguard Capital Management LLC | 2.92M | ▲ 8.64K |
| Disciplined Growth Investors Inc /Mn | 2.33M | ▼ 669.76K |
| First Trust Capital Management L.P. | 2.31M | ▲ 2.31M |
| Woodline Partners LP | 2.15M | ▲ 2.15M |
| Polar Asset Management Partners Inc. | 2.07M | ▲ 2.07M |
| State Street Corp | 2.00M | ▼ 32.80K |
| Alliancebernstein L.P. | 1.97M | ▲ 1.91M |
Held by 16 ETFs
Biggest fund positions in WEAV by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 26, 26 | Dubin Ryan | sell | 68,752 |
| Oct 26, 26 | Harvey Stuart C. JR | sell | 127,337 |
| Oct 26, 26 | Harvey Stuart C. JR | sell | 106,666 |
| Oct 26, 26 | McDermott Adrian | sell | 76,249 |
| Oct 26, 26 | Newton Tyler | sell | 64,405 |
| Oct 26, 26 | TOMLIN DEBORA B | sell | 124,677 |
| Oct 26, 26 | TOMLIN DEBORA B | sell | 106,666 |
| Oct 26, 26 | Robson Herbert Edward II | sell | 400,000 |
| Oct 26, 26 | Scanlon George P | sell | 153,681 |
| Oct 26, 26 | Waltman Tyler Otis | sell | 150,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our WEAV coverage
Recent articles, reports, and earnings notes.
No research on WEAV yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate WEAV report →Weave Awards Healthcare Heroes Grant to The People's Health Clinic in Park City, Utah
businesswire.com · Nov 19
149,000 Shares of Weave Communications, Inc. $WEAV Purchased by Alberta Investment Management Corp
defenseworld.net · Nov 17
Francisco Partners Completes Acquisition of Weave
businesswire.com · Oct 26
Weave Communications (NYSE:WEAV) versus Certara (NASDAQ:CERT) Head-To-Head Comparison
defenseworld.net · Oct 19
Weave Communications (NYSE:WEAV) versus HealthStream (NASDAQ:HSTM) Financial Contrast
defenseworld.net · Oct 18
Weave Earns 2026 Great Place To Work Certification™
businesswire.com · Oct 15
Are CSR, WEAV, DV Obtaining Fair Deals for their Shareholders?
prnewswire.com · Oct 13
Weave Communications Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Weave Communications, Inc. - WEAV
businesswire.com · Oct 13
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.